Skip to main content
The Journal of Prevention of Alzheimer's Disease logoLink to The Journal of Prevention of Alzheimer's Disease
. 2025 Feb 21;12(5):100091. doi: 10.1016/j.tjpad.2025.100091

Multisensory stimulation reduces neuropsychiatric symptoms and enhances cognitive function in older adults with dementia: A meta-analysis of randomized controlled trials

Tiara Octary a,b, Melati Fajarini a,c, Hidayat Arifin a,d,e, Ruey Chen a,f,g, Chien-Mei Sung h, Li-Fang Chang a,i,j, Chia-Hui Wang a, Kondwani Joseph Banda a,k, Kuei-Ru Chou a,f,l,m,
PMCID: PMC12183989  PMID: 39986906

Abstract

Objective

Multisensory stimulation defined as engaging multiple senses (visual, olfactory, auditory, gustatory, and tactile), has been demonstrated to improve older adults’ general health. However, its effectiveness in mitigating neuropsychiatric symptoms (NPSs) and cognitive deficits in older adults with dementia remains unclear. This meta-analysis evaluated the efficacy of multisensory stimulation in ameliorating NPSs and improving overall cognitive function in older adults with dementia.

Methods

We searched eight databases to September 2024 without restriction. Older adults with all stages of dementia aged 65 years and above were included. To estimate the pooled effect size, Hedge's g (g) values were calculated using a random-effects model. Heterogeneity was assessed using the Q, , and τ² statistics. Subgroup and meta-regression analyses were performed to identify moderators. Publication bias was assessed using Begg and Mazumdar's rank correlation and Egger's linear regression tests.

Results

This review included 16 studies (974 patients). Multisensory stimulation significantly reduced agitation (g= −0.96; 95 %CI= −1.44, −0.48), apathy (g= −1.27; 95 %CI= −2.08, −0.46), and depression (g= −0.28; 95 %CI= −0.48, −0.07). Moreover, the intervention significantly improved overall cognitive function (g= 0.30; 95 %CI= 0.09, 0.52). However, multisensory stimulation had no significant effect on anxiety (g= −0.81; 95 %CI= −1.79, 0.17). Significant heterogeneity was observed in agitation, apathy, and anxiety. Moreover, meta-regression analyses by educational level (junior high school and above) revealed significant moderators in agitation.

Conclusions

Multisensory stimulation shows promise as a non-pharmacological intervention for older adults with dementia. It may effectively mitigate NPSs and improve cognitive function into clinical practice as an alternative therapeutic.

Keywords: Multisensory stimulation, Snoezelen, Dementia, Older adult, Meta-analysis

1. Introduction

Neuropsychiatric symptoms (NPSs) are common and often more distressing than cognitive symptoms in patients with dementia; approximately 80 % of all patients with Alzheimer's disease develop these symptoms [1]. The ageing process is intricately linked with the emergence of NPSs, which are significant predictors of cognitive decline and dementia [2]. NPSs include behavioral domains such as agitation, apathy, depression, and anxiety [1]. NPSs, along with cognitive deficits, result in the loss of essential functions, substantially diminishing the quality of life for both patients and caregivers [1]. Interventions targeting NPSs can help improve the overall quality of life of patients with dementia and their caregivers by facilitating disease management and reducing caregiver burden.

Pharmacological treatment options for dementia often exhibit limited efficacy and can cause adverse effects. Therefore, nonpharmacological interventions, such as multisensory stimulation, have gained popularity as complementary therapeutic options [3]. Multisensory stimulation refers to stimulation of visual, auditory, tactile, olfactory, and gustatory senses, and that creates a space/ environment for enjoying a variety of sensory experiences and where gentle stimulation of the senses can be provided in a controlled way [4]. Visual stimuli, such as light effects from bubble tubes and fiber optic sprays, or the use of familiar images, can regulate the circadian rhythm, influencing both NPSs and cognitive function [4]. Olfactory stimuli, such as the aroma of spices and the fragrance of flowers, can aid in memory recall [5]. Auditory stimuli, such as music, serve as positive distractors and help stabilize agitated behaviors [6]. Gustatory stimuli, such as sweetened foods, address nutritional deficiencies in patients with dementia and increase food intake through appealing supplements [7]. Tactile stimuli, such as the warmth of a mug, can evoke positive emotional responses and memories [8].

Multisensory stimulation has been demonstrated to alleviate NPSs, such as agitation [9,10], apathy [11,12], depression [8], and anxiety [8,13] and improve cognitive function by reinforcing memory recall [2] among older adults with dementia. Therefore, multisensory stimulation holds promise as a nonpharmacological intervention for patients with dementia, particularly in ameliorating NPSs and improving cognitive function. Relevant meta-analyses have been conducted in various populations, such as children [14] and adults [15], and for various conditions, such as brain injury [16], autism [17], and stroke [18]. However, these meta-analyses have neither examined older adults or patients with dementia nor analyzed pooled estimates across a diverse range of outcome indicators (NPSs and cognitive function) or moderating factors. Thus, to address these research gaps and recognizing the importance of understanding the effect of multisensory intervention on the older adults with dementia population, given that this intervention has a positive impact on other populations, we conducted the present systematic review and meta-analysis of randomized controlled trials (RCTs) to investigate the effects of multisensory stimulation on NPSs and cognitive function in older adults with dementia. Our findings may aid health-care professionals, particularly nurses, in implementing effective nonpharmacological interventions for older adults with dementia.

2. Methods

2.1. Study design and eligibility criteria

This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines [19]. The review protocol was registered in the International Prospective Register of Systematic Review database (registration ID: CRD42024507054). Ethical approval was not required because the analysis relied on published, anonymized, and aggregated data.

Studies were included if they (1) focused on older adults (≥65 years) with all stages of dementia, diagnosed by neurologists or geriatricians on the Diagnostic and Statistical Manual of Mental Disorders criteria, International Classification of Diseases codes, Mini-Mental State Examination scores, Montreal Cognitive Assessment scores, Alzheimer's Disease Assessment Scale–Cognitive Subscale (ADAS-Cog), or Clinical Dementia Rating scores; (2) administered multisensory stimulation through ≥2 sensory modalities (such as visual, auditory, olfactory, gustatory, and tactile stimulation); (3) included a usual care, no treatment, or active control group; (4) assessed NPS subcategories (e.g., agitation, apathy, depression, and anxiety) and cognitive function; and (5) had an RCT design. Articles were excluded if they (1) focused on an irrelevant topics or populations (such as pharmacotherapy, physical therapy, cognitive training, others), (2) were reviews, (3) were non-research articles, (4) were descriptions of study protocols, (5) were based on irrelevant study designs, or (6) provided insufficient data in spite of our attempts to obtain full-text information by email.

2.2. Search strategy

A comprehensive search strategy was developed in collaboration with a university librarian. Population- and intervention-focused keywords were used to capture a broad range of outcomes. The search spanned eight databases, including CINAHL, Cochrane, Embase, ProQuest, PsycINFO, PubMed, Scopus, and Web of Science. The databases were searched with no time, region, or language restrictions imposed. Relevant articles published from database inception to September 2024 were screened for eligibility. Medical Subject Headings, Subject Headings, Psychological Index Terms, Main Subject, Emtree, and keywords were combined with Boolean operators (“AND” or “OR”) to identify RCTs focusing on “multisensory stimulation” and “dementia.” The search terms and strategies are presented in Tables S3 and S4. Forward citation searching was conducted, where databases were screened for articles that referenced published studies, and backward citation searching was also conducted, where studies in the reference lists of other systematic reviews and meta-analyses were screened for eligibility. Additional potentially eligible studies were identified through manual searches in Google Scholar (Fig. 1).

Fig. 1.

Fig. 1

Preferred reporting items for systematic reviews and meta-analyses flow diagram.

2.3. Study selection and data extraction

Two reviewers independently assessed relevant articles by using EndNote 20. After the removal of duplicate articles, titles and abstracts were screened on the basis of predefined inclusion and exclusion criteria. Then, a full-text review was performed to assess eligibility. Discrepancies were resolved through discussion with a third reviewer. The following information was extracted from each included study: author names, study country, dementia subtype/severity, diagnostic tool, study setting, sample characteristics, study design, group type, intervention characteristics (e.g., intervention setting, number of session, duration, and study period), and intervention outcomes (Table 1). The corresponding authors of eligible studies were contacted for clarification or additional information when necessary.

Table 1.

Multisensory stimulation interventions for older adults with dementia.

No Author (year),
country
Subtype/ severity of
dementia, tool,
study setting
Sample
characteristics
n (%); mean (SD)
Study design, group
type
Intervention
characteristics
Outcomes (tool) Time point
1. Andretta (2008),
United States
Subtype:
Alzheimer's dementia
Severity:
moderate dementia
Tool:
MMSE, 15.0 (2.3)
Study setting:
nursing home
Sample size
Overall: 84
EG: 41 (48.8 %)
CG: 43 (51.2 %)
Mean age: 85.8 (10.1)
Gender:
M: 15 (17.9 %)
F: 69 (82.1 %)
Study design:
RCT
EG: Snoezelen
Visual: +
Olfactory: +
Auditory: +
Gustatory: -
Tactile: +
CG: no treatment
Intervention setting:
Snoezelen room
Number of sessions:
1 session
Duration:
20 min/session
Study period:
1 session
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Anxiety (BAI)

  • -

    Cognition: NI

  • -

    Baseline

  • -

    During treatment: NI

  • -

    Post treatment:

    1-session

  • -

    Follow-up:

    1-week

    4-week

2. Bakshi (2004),
Canada
Subtype: NI
Severity:
moderate dementia
Tool:
MMSE, 9.5 (4.9)
Study setting:
hospital
Sample size
Overall: 40
EG: 20 (50.0 %)
CG: 20 (50.0 %)
Mean age: 78.0 (7.3)
Gender:
M: 24 (60.0 %)
F: 16 (40.0 %)
Study design:
RCT
EG: Snoezelen
Visual: -
Olfactory: +
Auditory: +
Gustatory: -
Tactile: +
CG: usual care
Intervention setting:
activity room
Number of sessions:
3 sessions/week
Duration:
30–40 min/session
Study period:
12 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (CMAI)

  • -

    Cognition: NI

  • -

    Baseline

  • -

    During treatment:

    6-session

  • -

    Post treatment:

    12-session

  • -

    Follow-up: NI

3. Goyal et al. (2021), Ireland Subtype: NI
Severity: moderate to severe dementia
Tool:
MMSE, 8.7 (7.0)
Study setting:
nursing home
Sample size
Overall: 88
EG: 48 (54.5 %)
CG: 40 (45.5 %)
Mean age: 84.8 (6.9)
Gender:
M: 20 (22.7 %)
F: 68 (77.3 %)
Study design:
RCT
EG: Snoezelen
Visual: +
Olfactory: +
Auditory: +
Gustatory: +
Tactile: +
CG: usual care
Intervention setting:
activity room
Number of sessions:
2 sessions/week
Duration:
45 min/session
Study period:
48 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Depression (CSDD);

    Anxiety (RAID)

  • -

    Cognition: NI

  • -

    Baseline

  • -

    During treatment:

    24-session

  • -

    Post treatment:

    48-session

  • -

    Follow-up: NI

4. Hong (2011),
Korea
Subtype:
Alzheimer's dementia
Severity: moderate dementia
Tool:
MMSE-KC, 12.2 (4.7)
Study setting:
nursing home
Sample size
Overall: 51
EG: 25 (49.0 %)
CG: 26 (51.0 %)
Mean age: 82.1 (6.5)
Gender:
M: 11 (21.6 %)
F: 40 (78.4 %)
Study design:
RCT
EG: Multisensory stimulation
Visual: +
Olfactory: +
Auditory: +
Gustatory: -
Tactile: +
CG: usual care
Intervention setting:
activity room
Number of sessions:
2 sessions/week
Duration:
55 min/session
Study period:
20 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (CMAI-K);

    Depression (CSDD)

  • -

    Cognition: (MMSE-KC)

  • -

    Baseline

  • -

    During treatment:

    10-session

  • -

    Post treatment:

    20-session

  • -

    Follow-up: NI

5. Hutson et al. (2014),
UK
Subtype: NI
Severity: moderate to severe dementia
Tool:
DSM-IV
MMSE, 4.9 (5.2)
Study setting:
nursing home
Sample size
Overall: 39
EG: 21 (53.8 %)
CG: 18 (46.2 %)
Mean age: 86.6 (6.7)
Gender:
M: 5 (13.9 %)
F: 34 (86.1 %)
Study design:
RCT
EG: Snoezelen
Visual: +
Olfactory: +
Auditory: +
Gustatory: +
Tactile: +
CG: usual care
Intervention setting:
activity room
Number of sessions:
2 sessions/week
Duration:
45–60 min/session
Study period:
14 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Depression (CSDD);

    Anxiety (RAID)

  • -

    Cognition: NI

  • -

    Baseline

  • -

    During treatment: NI

  • -

    Post treatment:

    14-session

  • -

    Follow-up: NI

6. Kor et al. (2024),
Hong Kong
Subtype: NI
Severity:
moderate dementia
Tool:
ICD-10
Study setting:
home
Sample size
Overall: 241
EG: 121 (50.2 %)
CG: 120 (49.8 %)
Mean age: 83.0 (8.0)
Gender:
M: 98 (40.8 %)
F: 142 (59.2 %)
Study design:
RCT
EG: multisensory (five senses box)
Visual: +
Olfactory: +
Auditory: +
Gustatory: +
Tactile: +
CG: usual care
Intervention setting:
NI
Number of sessions:
3 sessions/week
Duration:
45 min/session
Study period:
45 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms: NI

  • -

    Cognition: (MoCA 5-min protocol)

  • -

    Baseline

  • -

    During treatment: NI

  • -

    Post treatment:

    45-session

  • -

    Follow-up:

    12-week

7. Li et al. (2024),
China
Subtype:
Alzheimer dementia
Severity:
mild to severe dementia
Tool:
CCMD-3
Study setting:
hospital
Sample size
Overall: 80
EG: 40 (50.0 %)
CG: 40 (50.0 %)
Mean age: 75.3 (5.7)
Gender:
M: 43 (53.8 %)
F: 37 (46.3 %)
Study design:
RCT
EG: multisensory stimulation
Visual: +
Olfactory: +
Auditory: +
Gustatory: -
Tactile: +
CG: regular rehabilitation training
Intervention setting:
multisensory room
Number of sessions:
2 sessions/week
Duration:
60 min/session
Study period:
24 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (BEHAVE-AD);

    Apathy (AES);

    Anxiety (BEHAVE-AD)

  • -

    Cognition: NI

8. Maseda et al. (2014),
Spain
Subtype: NI
Severity:
moderate dementia
Tool:
GDS, stage 5
Study setting:
specialized elderly center
Sample size
Overall: 20
EG: 10 (50.0 %)
CG: 10 (50.0 %)
Mean age: 87.0 (5.6)
Gender:
M: 2 (10.0 %)
F: 18 (90.0 %)
Study design:
RCT
EG: multisensory stimulation
Visual: +
Olfactory: +
Auditory: +
Gustatory: -
Tactile: +
CG: usual care
Intervention setting:
Snoezelen room
Number of sessions:
2 sessions/week
Duration:
30 min/session
Study period:
32 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (CMAI);

    Depression (CSDD)

  • -

    Cognition (MMSE)

  • -

    Baseline

  • -

    During treatment:

    16-session

  • -

    Post treatment:

    32-session

  • -

    Follow-up:

    8-week

9. Maseda et al. (2018),
Spain
Subtype: NI
Severity:
severe dementia
Tool:
GDS, 6–7
Study setting:
nursing home
Sample size
Overall: 21
EG: 10 (47.6 %)
CG: 11 (52.4 %)
Mean age: 88.9 (6.7)
Gender:
M: 6 (28.6 %)
F: 15 (71.4 %)
Study design:
RCT
EG: multisensory stimulation
Visual: +
Olfactory: +
Auditory: +
Gustatory: -
Tactile: +
CG: music
Intervention setting:
Snoezelen room
Number of sessions:
2 sessions/week
Duration:
30 min/session
Study period:
24 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Depression (Interact Scale)

  • -

    Cognition: NI

  • -

    Baseline

  • -

    During treatment: NI

  • -

    Post treatment:

    24-session

  • -

    Follow-up: NI

10. Milev et al. (2008a),
Canada
Subtype: NI
Severity: NI
Tool:
DSM-IV
Study setting:
long-term care
Sample size
Overall: 11
EG: 5 (45.5 %)
CG: 6 (54.5 %)
Mean age: 84.6 (6.7)
Gender:
M: 3 (27.3 %)
F: 8 (72.7 %)
Study design:
Pilot RCT
EG: multisensory stimulation
Visual: +
Olfactory: -
Auditory: +
Gustatory: -
Tactile: +
CG: usual care
Intervention setting:
Snoezelen room
Number of sessions:
1 session/week
Duration:
30 min/session
Study period:
12 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (DOS)

  • -

    Cognition (MMSE)

  • -

    Baseline

  • -

    During treatment:

    4-session,

    8-session

  • -

    Post treatment:

    12-session

  • -

    Follow-up:

    24-week

11. Milev et al. (2008b),
Canada
Subtype: NI
Severity: NI
Tool:
DSM-IV
Study setting:
long-term care
Sample size
Overall: 13
EG: 7 (53.8 %)
CG: 6 (46.2 %)
Mean age: 85.5 (5.4)
Gender:
M: 2 (15.4 %)
F: 11 (84.6 %)
Study design:
Pilot RCT
EG: multisensory stimulation
Visual: +
Olfactory: -
Auditory: +
Gustatory: -
Tactile: +
CG: usual care
Intervention setting:
Snoezelen room
Number of sessions:
3 sessions/week
Duration:
30 min/session
Study period:
36 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (DOS)

  • -

    Cognition (MMSE)

  • -

    Baseline

  • -

    During treatment:

    12-session,

    24-session

  • -

    Post treatment:

    36-session

  • -

    Follow-up:

    24-week

12. Safavi et al. (2013),
Iran
Subtype:
Alzheimer's dementia
Severity:
moderate dementia
Tool:
DSM-IV-TR
MMSE, 15.9 (3.2)
Study setting:
elderly women care center
Sample size
Overall: 52
EG: 26 (50.0 %)
CG: 26 (50.0 %)
Mean age: NI
Gender:
M: 0 (0 %)
F: 52 (100 %)
Study design:
RCT
EG: Multisensory stimulation
Visual: +
Olfactory: +
Auditory: +
Gustatory: -
Tactile: +
CG: no treatment
Intervention setting:
hall in elderly women care center
Number of sessions:
2 sessions/day
Duration:
45–60 min/session
Study period:
20 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms: NI

  • -

    Cognition (MMSE)

  • -

    Baseline

  • -

    During treatment: NI

  • -

    After treatment:

    20-session

  • -

    Follow-up: NI

13. Sanchez et al. (2016),
Spain
Subtype: NI
Severity:
severe dementia
Tool:
GDS, stage 6–7
Study setting:
specialized dementia elderly center
Sample size
Overall: 22
EG: 11 (50.0 %)
CG: 11 (50.0 %)
Mean age: 87.0 (6.7)
Gender:
M: 2 (9.1 %)
F: 20 (90.9 %)
Study design:
Pilot RCT
EG: multisensory stimulation
Visual: +
Olfactory: +
Auditory: +
Gustatory: -
Tactile: +
CG: activity group
Intervention setting:
Snoezelen room
Number of sessions:
2 sessions/week
Duration:
30 min/session
Study period:
32 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (CMAI); Depression (CSDD)

  • -

    Cognition (SMMSE)

  • -

    Baseline

  • -

    During treatment:

    16-session

  • -

    After treatment:

    32-session

  • -

    Follow-up:

    8-week

14. Solé et al. (2023),
Spain
Subtype: NI
Severity: NI
Tool:
FAST, NI
Study setting:
nursing home
Sample size
Overall: 81
EG: 38 (46.9 %)
CG: 43 (53.1 %)
Mean age: 88.0 (6.1)
Gender:
M: 13 (16.0 %)
F: 68 (84.0 %)
Study design:
RCT
EG: Snoezelen
Visual: +
Olfactory: +
Auditory: +
Gustatory: +
Tactile: +
CG: reminiscence
Intervention setting:
Snoezelen room
Number of sessions:
2 sessions/week
Duration:
30 min/session
Study period:
24 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (CMAI);

    Depression (CSDD);

    Anxiety (HAS)

  • -

    Cognition: NI

  • -

    Baseline

  • -

    During treatment: NI

  • -

    After treatment:

    24-session

  • -

    Follow-up: NI

15. Staal et al. (2007),
United States
Subtype: NI
Severity:
moderate dementia
Tool:
MMSE, 15.5 (4.3)
Study setting:
hospital
Sample size
Overall: 24
EG: 12 (50.0 %)
CG: 12 (50.0 %)
Mean age: 76.2 (4.4)
Gender:
M: 8 (33.3 %)
F: 16 (66.7 %)
Study design:
RCT
EG: Snoezelen
Visual: NI
Olfactory: NI
Auditory: NI
Gustatory: NI
Tactile: NI
CG: usual care
Intervention setting:
multisensory room
Number of sessions:
3 sessions/week
Duration:
25–30 min/session
Study period:
15 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (PAS);

    Apathy (SANS-AD)

  • -

    Cognition: NI

  • -

    Baseline

  • -

    During treatment:

    1 to 5 sessions

  • -

    After treatment:

    6-session

  • -

    Follow-up: NI

16. Verkaik et al. (2019),
Netherlands
Subtype: NI
Severity:
moderate dementia
Tool:
GDS, stage 5–6
Study setting:
nursing home
Sample size
Overall: 47
EG: 24 (51.1 %)
CG: 23 (48.9 %)
Mean age: 87.0 (6.4)
Gender:
M: 12 (25.5 %)
F: 35 (74.5 %)
Study design:
Pilot RCT
EG: multisensory stimulation
Visual: +
Olfactory: +
Auditory: +
Gustatory: +
Tactile: +
CG: usual care
Intervention setting:
multisensory room
Number of sessions:
3 sessions/week
Duration:
30 min/session
Study period:
36 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms:

    Agitation (CMAI);

    Depression (CSDD);

    Apathy (AES)

  • -

    Cognition: NI

  • -

    Baseline

  • -

    During treatment: NI

  • -

    After treatment:

    36-session

  • -

    Follow-up: NI

17. Yan (2018)
China
Subtype:
Senile dementia
Severity:
mild dementia
Tool:
MoCA, 23.1 (3.3)
Study setting:
hospital
Sample size
Overall: 66
EG: 33 (50.0 %)
CG: 33 (50.0 %)
Mean age: 72.7 (2.0)
Gender:
M: 42 (63.6 %)
F: 24 (36.4 %)
Study design:
RCT
EG: multisensory stimulation
Visual: +
Olfactory: +
Auditory: +
Gustatory: -
Tactile: +
CG: routine rehabilitation training
Intervention setting:
multisensory room
Number of sessions:
2 sessions/week
Duration:
30 min/session
Study period:
24 sessions
Primary outcomes:
  • -

    Neuropsychiatric symptoms

  • -

    Cognition (MoCA)

  • -

    Baseline

  • -

    During treatment:

    12-session

  • -

    After treatment:

    24-session

  • -

    Follow-up: NI

Abbreviations: AES, Apathy Evaluation Scale; BAI, Beck Anxiety Inventory; BEHAVE-AD, Behavioral Pathology in Alzheimer's Disease Rating Scale; CCMD-3, Chinese Classification and Diagnostic Criteria of Mental Disorders, Third Edition; CG, control group; CMAI, Cohen–Mansfield Agitation Inventory; CSDD, Cornell Scale for Depression in Dementia; DOS, Daily Observation Scale; DSM-IV-TR, Diagnostic and Statistical Manual, Fourth Edition, Text Revision; EG, experimental group; F, female; FAST, Functional Assessment Staging Tool; GDS, Global Deterioration Scale; HAS, Hamilton Anxiety Rating Scale; ICD, International Classification of Diseases; M, male; MMSE, Mini-Mental State Examination; MMSE-KC, Korean version of Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; NI, no information; NPS, neuropsychiatric symptom; PAS, Pittsburgh Agitation Scale; RAID, Rating Anxiety in Dementia; RCT, randomized controlled trial; SANS-AD, Scale for the Assessment of Negative Symptoms in Alzheimer's Disease; SMMSE, Severe Mini-Mental State Examination.

2.4. Outcomes measures and instruments

The primary study outcomes were the NPS which consists of agitation, apathy, depression, and anxiety. Agitation was evaluated using the Behavioral Pathology in Alzheimer's Disease Rating Scale, Cohen–Mansfield Agitation Inventory, Daily Observation Scale, and Pittsburgh Agitation Scale. Apathy was evaluated using the Apathy Evaluation Scale and the Scale for the Assessment of Negative Symptoms in Alzheimer's Disease. Depression was evaluated using the Cornell Scale for Depression in Dementia and Interact Scale. Anxiety was evaluated using the Beck Anxiety Inventory, Behavioral Pathology in Alzheimer's Disease Rating Scale, Hamilton Anxiety Scale, and Rating Anxiety in Dementia scale.

The secondary study outcome was cognitive function. It was assessed by measuring overall cognitive function or specific cognitive domains such as complex attention (sustained attention, divided attention, selective attention, and processing speed), executive function (planning, decision making, working memory, responding to feedback/ error correction, overriding habits/ inhibition, and mental flexibility), learning and memory (immediate memory, recent memory [including free recall, cued recall, and recognition memory], very-long-term memory [semantic; autobiographical], and implicit learning), language (expressive language [including naming, word finding, fluency, and grammar, and syntax], and receptive language), perceptual-motor (abilities, subsumed under the term visual perception, visuo-constructional, perceptual-motor, praxis, and gnosis), and social cognition (recognition of emotions and theory of mind) [20]. Cognitive function was primarily evaluated by neurologists or geriatricians on the basis of the Diagnostic and Statistical Manual of Mental Disorders criteria or the International Classification of Diseases codes. Additional instruments included the Mini-Mental State Examination, Montreal Cognitive Assessment, and Severe Mini-Mental State Examination.

2.5. Data synthesis and analysis

The random-effects model in Comprehensive Meta-Analysis software (version 3.0) was used to account for statistically significant heterogeneity [21]. Hedge's g (g) values with 95 % confidence intervals (CIs) were calculated to estimate the pooled effect size for continuous data and incorporates a correction factor that addresses this bias, providing more accurate effect size estimates, especially when dealing with smaller sample sizes [22]. After treatment and follow-up analyses were performed using the pooled estimates for NPS subcategories (agitation, apathy, depression, and anxiety) and cognitive function. g providing more accurate effect size estimates, especially when dealing with smaller sample sizes [22]. g values were interpreted as follows: 0.20–0.49, small effect; 0.50–0.79, medium effect; and ≥0.80, large effect. Statistical significance was set at p <0.05 [23,24]. A significant, negative g value indicated decreased NPSs, whereas a significant, positive g value indicated improved cognitive function.

Heterogeneity was assessed using the I2, τ2, and Cochrane Q statistics; a p value of <0.10 indicated significant heterogeneity. I2 values were interpreted as follows: <25 % indicated low heterogeneity, ≥25 % to <75 % indicated moderate heterogeneity; and ≥75 % indicated high heterogeneity [25]. Prediction intervals (95 % PI) were calculated to estimate the range of true effect sizes in similar future studies [26]. Moderator analyses—subgroup and meta-regression analyses—were performed to identify potential sources of significant heterogeneity. Categorical variables were subject to subgroup analyses; specifically, the included studies were segmented by the setting of the study; the setting, number of session, and length of the intervention; and the number of senses targeted (all five senses, four senses [visual, olfactory, auditory, and tactile], or three senses [visual, auditory, and tactile or olfactory, auditory, and tactile]). Continuous variables were subjected to meta-regression analyses [27]. A p <0.05 indicated significant moderation. For each outcome category with ≥10 studies, publication bias was independently evaluated using Begg and Mazumdar's rank correlation test [28,29] and Egger's linear regression test [28,29]; a p >0.10 indicated no publication bias [30]. The trim-and-fill method was used to adjust for publication bias [31]. Furthermore, a sensitivity analysis was conducted to assess the robustness of our findings. This involved excluding studies with large and small contribution (identified by g values) to determine if the overall effect size was sensitive to individual studies, indicating potential instability or heterogeneity [32]. The results were compared with those of the initial pooled effect size analysis to validate the robustness of our findings. The present systematic review and meta-analysis adhered to prevailing standards on participant characteristics, intervention characteristics, comparators, outcomes, study designs, time-to-event data, continuous data, ordinal scales, cluster-RCTs, cross-over trials, and any additional analyses [33].

2.6. Quality assessment

Two reviewers independently evaluated the quality of the included RCTs by using the revised Cochrane risk-of-bias tool (version 2) [34]. Discrepancies were resolved through discussion with a third reviewer. Studies were classified as having a high risk of bias, some concerns, or a low risk of bias on the basis of the final quality assessment results.

3. Results

3.1. Study inclusion and characteristics

The literature search returned 10,753 articles. After the removal of 3908 duplicate articles, 6845 were subjected to title and abstract screening. From these, 6826 articles were excluded for the following reasons: irrelevant topics (n = 6518), irrelevant populations (n = 136), reviews (n = 91), non-research articles (n = 21), study protocol (n = 9), irrelevant study designs (n = 46), and irrelevant outcome measures (n = 5). A full-text review was performed for 19 studies. Six articles were excluded because of the unavailability of the full text despite attempts to contact the authors. Citation searches and manual searches through Google Scholar returned three additional articles. Ultimately, 16 studies were included in the meta-analysis; a complete list of references is presented in Table S5. Among the included studies, one [35] had a three-arm design; this resulted in findings on a total of 17 effect sizes (Fig. 1). Among the included RCT articles, none were double-blinded. This absence is primarily attributable to the nature of multisensory stimulation interventions.

The sample sizes of the studies ranged from 11 to 241; the total number of patients (sum of the experimental and control groups) was 974. Dementia was the most common condition, accounting for 11 (68.8 %), followed by Alzheimer disease accounting 4 (25.0 %), and 1 (6.3 %) of Senile dementia. Approximately 68.7 % of the patients were women. The patients’ mean age was 82.7 ± 8.4 years. Their mean Mini-Mental State Examination score (on the basis of seven studies) was 11.7 ± 6.0. The studies were conducted across America (4 studies), Asia (5 studies), and Europe (7 studies). As shown in Table S7, most patients resided in nursing homes or long-term care facilities (62.5 %).

Multisensory stimulation targeted all five senses in five studies (31.3 %). Most interventions were administered in multisensory rooms (68.8 %). The session duration of multisensory stimulation ranged from 4 to 24 weeks. The number of sessions were held 1–3 times a week, and each session lasted 20–60 min. The study period ranged from 1 to 48 sessions and the follow-up period ranged from 1 to 24 weeks (Table 1).

3.2. Results of quality assessment

Study quality was assessed using the latest Cochrane risk-of-bias tool. Among the 16 included studies, 15 used an intention-to-treat analysis, whereas one used a per-protocol analysis. Among the 15 studies that used an intention-to-treat analysis, 4 (26.7 %) had a low risk of bias, whereas another 4 (26.7 %) had some concerns of bias (Figure S2).

3.3. Effect of multisensory stimulation on NPSs

Multisensory stimulation significantly reduced the severity of the NPSs including agitation, apathy, and depression, with no significant effect on anxiety (Fig. 2).

Fig. 2.

Fig. 2

Main findings of this study.

3.3.1. Agitation

The meta-analysis revealed that multisensory stimulation considerably reduced agitation in older adults with dementia, with a large effect size. A total of 10 effect sizes from 9 studies [[11], [12], [13],[35], [36], [37], [38], [39], [40]] involving 386 patients were evaluated to investigate the effects of multisensory stimulation on agitation. The random-effects model indicated that multisensory stimulation significantly alleviated agitation (g = −0.96; 95 %CI = −1.44 to −0.48; p <0.001). Significant heterogeneity was observed for agitation (Q = 41.98; p = <0.001, I2 = 78.56 %; τ2 = 0.45; Table 2). Subgroup analyses by study setting; intervention setting, number of session, or length; and number of senses revealed no significant moderators. Moreover, meta-regression analyses by educational level (junior high school and above) revealed significant moderators, while age, gender (male, female), and educational level (elementary school and below) revealed no significant moderators (Table 3).

Table 2.

Effects of multisensory stimulation on neuropsychiatric symptoms and cognitive function.

No. Outcomes Time point k (n) Effect size
Heterogeneity
Hedges’ g 95 %, CI Z value p value Q statistic df (Q) p value I2 ( %) τ2
1. Neuropsychiatric symptoms
(a) Agitation Posttest 10 (386) −0.96 −1.44 −0.48 −3.90 <0.001 41.98 9 <0.001 78.56 0.45
(b) Apathy Posttest 3 (151) −1.27 −2.08 −0.46 −3.07 0.002 9.77 2 0.008 79.53 0.40
(c) Depression Posttest 8 (356) −0.28 −0.48 −0.07 −2.66 0.008 5.28 7 0.625 0.00 0.00
(d) Anxiety Posttest 5 (359) −0.81 −1.79 0.17 −1.62 0.104 74.73 4 <0.001 94.65 1.17
2. Cognitive function Posttest 6 (452) 0.30 0.09 0.52 2.75 0.006 5.81 5 0.325 13.99 0.01
Follow-up 5 (307) 0.42 0.20 0.64 3.70 <0.001 1.15 4 0.886 0.00 0.00

Effects were analyzed using a random-effects model.

Abbreviations: CI, confidence interval; k, number of studies; n, number of patients.

Table 3.

Results of the moderator analysis for the effect of multisensory stimulation on agitation and anxiety.

Categorical variables Agitation
Anxiety
k Hedge's g 95 % CI p value k Hedge's g 95 % CI p value
Study setting
 Noninstitutional 3 −1.26 −1.83 −0.69 0.327 2 −0.48 −1.35 0.39 0.555
 Institutional 7 −0.83 −1.49 −0.16 3 −1.05 −2.73 0.63
Number of senses targeted
 5 senses 2 −1.70 −2.74 −0.67 0.228 3 −0.06 −0.34 0.22 0.081
 4 senses 5 −0.63 −1.31 0.05 2 −1.96 −4.08 0.15
 3 senses 3 −1.04 −1.56 −0.53 0 0 0 0
Intervention setting
 Activity room 2 −0.72 −1.65 0.22 0.583 2 −0.01 −0.38 0.36 0.096
 Multisensory room 8 −1.02 −1.57 −0.47 3 −1.35 −2.87 0.18
Intervention frequency
 Twice a week 6 −0.92 −1.71 −0.14 0.655 NA NA NA NA NA
 More than twice a week 3 −1.13 −1.55 −0.71 NA NA NA NA
Intervention length (min/session)
 ≤30 min 7 −0.90 −1.54 −0.26 0.778 2 −1.59 −4.44 1.27 0.396
 >30 min 3 −1.06 −1.95 −0.17 3 −0.32 −0.94 0.29

Continuous variable k Coefficient 95 % CI p value k Coefficient 95 % CI p value

Mean age 10 0.03 −0.09 0.15 0.580 5 0.02 −0.23 0.27 0.868
Male (%) 10 -0.02 -0.04 0.01 0.270 5 -0.00 -0.08 0.07 0.934
Female (%) 10 0.02 -0.01 0.04 0.270 5 0.00 -0.07 0.08 0.933
Elementary school and below (%) 4 -0.06 -0.17 0.05 0.278 NA NA NA NA NA
Junior high school and above (%) 4 -0.05 -0.09 -0.01 0.022 NA NA NA NA NA

A p value of <0.05 indicates a significant effect; k denotes the number of effect size.

Abbreviation: CI, confidence interval; NA, not applicable.

No publication bias was detected. A Begg and Mazumdar's rank correlation test, performed using Kendall's tau without continuity correction, yielded a p = 0.420, whereas an Egger's linear regression test yielded a p = 0.194 (95 %CI = −2.32 to 9.74; Figure S1).

3.3.2. Apathy

The meta-analysis revealed that multisensory stimulation significantly reduced apathy in older adults with dementia, with a large effect size. Three studies [11,12,40] involving 151 patients investigated the effect of multisensory stimulation on apathy. The random-effects model indicated that multisensory stimulation significantly alleviated apathy (g = −1.27; 95 %CI = −2.08 to −0.46; p = 0.002). Significant heterogeneity was observed for apathy (Q = 9.77; p = 0.008, I2 = 79.53 %; τ2 = 0.40; Table 2). Given the limited number of studies and the presence of significant heterogeneity, no moderator analysis was performed for this outcome.

3.3.3. Depression

The meta-analysis revealed that multisensory stimulation significantly reduced depression in older adults with dementia. Eight studies [8,12,13,[37], [38], [39],41,42] involving 356 patients investigated the effect of multisensory stimulation on depression. The random-effects model indicated that multisensory stimulation significantly alleviated depression (g = −0.28; 95 %CI = −0.48 to −0.07; p = 0.008). No significant heterogeneity was observed for depression (Q = 5.28; p = 0.625; I2 = 0.00 %; τ2 = 0.00; Table 2).

3.3.4. Anxiety

The meta-analysis suggested that multisensory stimulation reduced anxiety in older adults with dementia; however, further studies are needed to confirm this effect. Five studies [8,11,13,41,43] involving 359 patients investigated the effect of multisensory stimulation on anxiety. The random-effects model indicated that multisensory stimulation nonsignificantly alleviated anxiety (g = −0.81; 95 %CI = −1.79 to 0.17; p = 0.104). Significant heterogeneity was observed for anxiety (Q = 74.73; p <0.001; I2 = 94.65 %; τ2 = 1.17; Table 2). Subgroup analyses by study setting; intervention setting, number of sesssion, or length; and number of senses revealed no significant moderators. Similarly, meta-regression analyses by age, gender (male, female), and educational level (elementary school and below; junior high school and above) revealed no significant moderators (Table 3).

3.4. Effect of multisensory stimulation on cognitive function

The meta-analysis revealed that multisensory stimulation significantly improved cognitive function in older adults with dementia (Fig. 2). Six studies [2,[37], [38], [39],[44], [45], [46]] involving 452 patients investigated the effect of multisensory stimulation on cognitive function. The random-effects model indicated that multisensory stimulation significantly improved cognition at post-test (g = 0.30; 95 %CI = 0.09 to 0.52; p = 0.006). No significant heterogeneity was observed for cognitive function (Q = 5.81; p = 0.325; I2 = 13.99 %; τ2 = 0.01; Table 2). By contrast, five effect sizes in four studies [2,35,38,39] involving 307 patients reported a significant effect at follow-up (analyzed using a random-effects model: g = 0.42; 95 %CI = 0.20 to 0.64; p < 0.001); no significant heterogeneity was observed (Q = 1.15; p = 0.886; I2 = 0.00 %; τ2 = 0.00; Table 2).

3.5. Results of sensitivity analysis

Sensitivity analysis was conducted by removal one study with large or small contributions. Solé, Celdrán [13] in agitation, Yang, Yu [11] in apathy, Andretta [43] in anxiety, and Safavi, Yahyavi [45] in cognitive function were excluded due to large contributions, while Maseda, Sánchez [38] was excluded due to small contribution. The results remained stable, indicating the robustness of the results of this meta-analysis (Table S8).

4. Discussion

This study revealed that multisensory stimulation significantly reduced various NPSs, particularly agitation, apathy, and depression, in older adults with dementia. Furthermore, it substantially improved cognitive function in this population. However, multisensory stimulation exerted no significant effect on anxiety.

4.1. Effect of multisensory stimulation on NPSs

Multisensory stimulation effectively mitigated the following NPS subcategories: agitation, apathy, and depression. It exhibited a large effect in reducing agitation. The amygdala, a limbic brain region sensitive to threats, activates areas that regulate the release of stress hormones, contributing to agitation [47]. Multisensory stimulation can influence these brain areas, leading to a reduction in agitation [9,10]. Visual stimulation, such as exposure to calming visual stimuli and engaging activities, can redirect attention and reduce agitation [13]. Olfactory stimulation, such as smelling pleasant and familiar scents, can evoke positive emotions and memories, thereby alleviating agitation [12]. Auditory stimulation, such as listening to calming music and familiar sounds, can induce relaxation and reduce stress, ultimately reducing agitation [10]. Gustatory stimulation, such as consuming familiar and palatable foods, can enhance comfort and reduce agitation [13,48]. Tactile stimulation, such as gentle touch and exposure to familiar textures, can promote relaxation and reduce anxiety, thereby improving overall well-being [10,49]. Overall, a multisensory approach that combines calming visual stimuli, pleasant scents, gentle sounds, familiar tastes, and comforting touch is often the most effective approach to reduce agitation in older adults with dementia. Our moderator analysis indicated that higher levels of education in older adults were significant moderator with a greater reduction in agitation. Previous study has revealed that older adults with higher education levels may exhibit lower levels of neuropsychiatric symptoms, potentially due to better cognitive reserve and emotional intelligence [50]. Meanwhile, study setting, intervention setting, number of session or length of intervention, number of senses stimulated, age, gender (male, female), and educational level (elementary school and below) did not emerge as significant moderators of agitation among older adults with dementia in our analysis.

Multisensory stimulation exhibited a large and significant effect in reducing apathy, with significant reductions in this NPS observed across the studies. It reduced the level of apathy in the intervention group [11]. People with apathy, which is associated with a lack of motivation, often exhibit similar changes in specific brain areas, such as the medial frontal cortex (including the anterior cingulate cortex, medial orbitofrontal cortex, and ventral striatum) and subcortical structures [51]. By combining various stimulation techniques, multisensory stimulation interventions create a calming and engaging environment to improve mood, reduce feelings of isolation, and counter the sensory deprivation associated with dementia and apathy [11,12]. These effects align with the prevailing understanding that multisensory stimulation, by offering relaxing aromas, real touch, lighting effects, and meditation music, stimulates patients’ sensory organs, such as those associated with smell, touch, vision, hearing, and taste; thus, multisensory stimulation effectively promotes activity in brain regions such as the orbitofrontal cortex and amygdala, which regulate emotion and motivation and are influenced by sensory input [11,52]. These findings suggest that multisensory environments help reduce passive behaviors by encouraging interaction with sensory stimuli, which, in turn, enhances motivation and engagement.

Multisensory stimulation also alleviated depressive symptoms. It considerably reduced depression in the intervention group [8]. The prefrontal cortex, which regulates executive function, decision-making, and mood regulation, exhibits reduced activity and altered connectivity in people with depression [53]. Patients with Alzheimer's disease lacking environmental stimulation are highly susceptible to depression, and their diminishing sensory perception with age indicates disease deterioration or progression [11]. However, interventions engaging multiple senses—for example, those combining auditory stimulation (music), olfactory stimulation (aromatherapy), and tactile stimulation (relaxation massage)—may help improve mood and create a stimulating and supportive environment to increase engagement and interaction, which can counteract feelings of sadness and withdrawal [8]. Furthermore, intervention settings and materials in multisensory rooms foster pleasant experiences and sensations and create a calming ambience [54]. Our meta-analysis indicated that multisensory stimulation significantly ameliorated depressive symptoms; thus, it holds promise as an adjunct treatment for depression in patients with dementia.

Although multisensory stimulation alleviated anxiety, the result was nonsignificant. This finding is consistent with others in the literature; minimal effects on anxiety may be attributable to the short-term effect of the intervention [8]. However, a study indicated that familiar, calming stimuli such as music and tactile objects can help reduce feelings of fear or anxiety in patients with dementia [4]. Consistent, gentle sensory input from multisensory stimulation may soothe anxiety by creating a predictable and comfortable environment. Our moderator analysis indicated that among the interventions that were delivered in institutional settings, those that were administered in multisensory rooms, engaged four of the five senses, and lasted <30 min were more effective than others in reducing anxiety, particularly in younger individuals. However, the overall effect was nonsignificant.

4.2. Effect of multisensory stimulation on cognitive function

We found that multisensory stimulation significantly improved cognitive function in older adults with dementia. Similar findings have been reported by other studies [2,3,37]. The cerebrum regulates various cognitive abilities, such as attention, executive function, memory, language, and visuospatial skills [55]. Multisensory stimulation interventions based on familiarity stimulate multiple senses to recall long-held memories and engage patients in games or activities that they had participated in when younger. For instance, each session begins with a reality orientation to familiarize patients with time, place, and people; this is followed by various activities (e.g., creating handicrafts, garnishing fruits/vegetables, compiling photograph albums, and engaging in horticulture) to stimulate attention, executive function, and visuospatial skills. Then, additional activities such as guessing songs, singing or dancing to musical instruments, and compiling photographs are conducted to reinforce memory [2]. Some activities include discussions on items, their names, and purposes, encouraging patients to access implicit memories by recalling the past. Thus, cognitively stimulating activities in a multisensory context activate neuronal pathways in patients with dementia [56]. Although our study indicated modest improvements in cognition, the finding suggests that multisensory stimulation can help preserve or slightly enhance cognitive processing, likely by promoting neural engagement and plasticity. Follow-up analyses, particularly in studies with relatively long intervention durations, revealed that the aforementioned cognitive benefits persist over time.

4.3. Strengths and limitations

Our study has several strengths. First, this is the most comprehensive meta-analysis to date, providing data on the efficacy of multisensory stimulation in managing NPSs and cognitive deficits in older adults with dementia. Second, specific outcomes related to NPS subcategories and cognitive function were determined in this study. Third, eight databases were searched to identify all eligible RCTs; moreover, reference lists were manually reviewed without imposing any restrictions on language, region, or publication year. Finally, moderator analyses were performed to explore the heterogeneity between the included studies. However, this study also has some limitations. The exclusion of articles with insufficient data might have affected the estimated effect sizes, although attempts were made to contact corresponding authors to obtain missing data. The included studies were not double-blinded, as this limitation is inherent in studies involving multisensory stimulation interventions, given the difficulty of blinding both participants and intervention providers due to the nature of the stimuli involved. Future research could incorporate a sham condition with minimal multisensory stimulation as a potential solution to enhance methodological rigor. Measuring cognitive function using MMSE has limitations in sensitivity and specificity, particularly in detecting subtle cognitive changes in people with dementia. Furthermore, this meta-analysis did not present the results of the effects of multisensory stimulation on specific domains of cognitive function due to the limited amount of data available from Randomized Controlled Trials. The current findings suggest that multisensory stimulation enhances cognitive function; however, the evidence remains preliminary and requires cautious interpretation. Future research should utilize more precise cognitive assessment tools, such as the ADAS-Cog, to provide a more reliable and standardized measure of cognitive outcomes. Similarly, we did not present the results for overall NPSs and other domains (except agitation, apathy, depression, and anxiety) due to limited available data. This study was limited by the number of included studies and the presence of heterogeneity, which impacts generalizability. Consequently, it is challenging to conclude which specific multisensory stimulation targeting particular sensory modalities will be the most effective for NPSs and cognitive function. Including a larger number of studies in future research could enhance the robustness of the results. Furthermore, the lack of follow-up analyses in some of the included studies limited our ability to evaluate the effects of multisensory stimulation on the study outcomes. Future studies should include follow-up analyses to clarify the short- and long-term effects of multisensory stimulation and the sustainability of these effects over time.

5. Conclusion

Our meta-analysis provides compelling evidence that multisensory stimulation serves as an effective nonpharmacological intervention for managing NPSs and cognitive functions in older adults with dementia. The findings indicate that this intervention exerts large and significant effects in alleviating agitation and apathy and a significant effect in alleviating depression. Furthermore, multisensory stimulation significantly improved cognitive function, with benefits sustained over follow-up periods. However, the intervention exerted no significant effect on anxiety. Nonetheless, multisensory stimulation holds promise as a valuable complementary therapy in dementia care. The intervention's ability to address multiple NPSs while supporting cognitive function makes it as a promising strategy for enhancing patients’ quality of life and reducing caregiver burden. Future studies should focus on optimizing intervention protocols, exploring factors that influence intervention efficacy, and investigating long-term outcomes. Combining multisensory stimulation with other nonpharmacological approaches may amplify its therapeutic potential. In conclusion, multisensory stimulation offers a safe and effective strategy for managing the complex symptoms of dementia. Integrating it into comprehensive care plans may significantly enhance the well-being of patients with dementia and provide support to their caregivers. By mitigating challenging behaviors and promoting patient engagement, health-care professionals, particularly nurses, can holistically meet patients’ psychological and cognitive needs. This approach also offers a viable alternative to pharmacological therapy, reducing reliance on medications and minimizing their adverse effects. Overall, this meta-analysis highlights multisensory stimulation as a promising intervention exerting significant positive effects on NPSs (particularly agitation, apathy, and depression) and cognitive function.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Declaration of generative AI

I confirm that I have not used any AI at all.

CRediT authorship contribution statement

Tiara Octary: Writing – original draft, Methodology, Formal analysis, Data curation, Conceptualization. Melati Fajarini: Writing – review & editing, Validation. Hidayat Arifin: Writing – review & editing, Visualization. Ruey Chen: Writing – review & editing, Visualization. Chien-Mei Sung: Validation, Formal analysis. Li-Fang Chang: Writing – review & editing, Validation. Chia-Hui Wang: Writing – review & editing, Validation. Kondwani Joseph Banda: Writing – review & editing, Validation. Kuei-Ru Chou: Writing – review & editing, Validation, Supervision, Conceptualization.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

The findings and conclusions in this paper are those of the authors, who are responsible for its contents.

Footnotes

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.tjpad.2025.100091.

Appendix. Supplementary materials

mmc1.docx (13.6KB, docx)
mmc2.docx (81KB, docx)
mmc3.pdf (8.3KB, pdf)
mmc4.pdf (68.1KB, pdf)

References

  • 1.Radue R, Walaszek A, Asthana S. Vol. 167. 2019. Neuropsychiatric symptoms in dementia; pp. 437–454. (Handbook of clinical neurology). [DOI] [PubMed] [Google Scholar]
  • 2.Kor PPK, Parial LL, Yu CTK, Liu JYW, Liu DPM, Hon JMK. Effects of a family caregiver-delivered multisensory cognitive stimulation intervention for older people with dementia during coronavirus 2019: a randomized controlled trial. Gerontologist. 2024;64(2):1–12. doi: 10.1093/geront/gnad054. [DOI] [PubMed] [Google Scholar]
  • 3.Machado BM, CdSS Castro. Use of multisensory stimulation in institutionalized older adults with moderate or severe dementia. Dement Neuropsychol. 2022;16(2):202–212. doi: 10.1590/1980-5764-DN-2021-0022. 2024-02-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jakob A, Collier L. 2014. How to make a sensory room for people living with dementia - A Guide book. [Google Scholar]
  • 5.Rowland E. David and Charles; 2024. The healing power of scent: a beginner's guide to the power of essential oils. [Google Scholar]
  • 6.Herrity K. Policy Press; 2024. Sound, order and survival in prison: the rhythms and routines of hmp midtown. [Google Scholar]
  • 7.Dominguez LJ, Veronese N, Vernuccio L, et al. Nutrition, physical activity, and other lifestyle factors in the prevention of cognitive decline and dementia. Nutrients. 2021;13(11) doi: 10.3390/nu13114080. Nov 15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Goyal AR, Engedal K, Benth JŠ, Strøm BS. Effects of the sonas program on anxiety and depression in nursing home residents with dementia: a 6-month randomized controlled trial. Dement Geriatr Cogn Dis Extra. 2021;11(2):151–158. doi: 10.1159/000516804. 2024-02-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Alruwaili AN, Alruwaili MM, Ramadan OME, Ali SI, Shaban M. Nursing strategies for enhancing calm in older Arabs with dementia: integrating Snoezelen methods, aromatherapy, and personal items to reduce agitation. Geriatr Nurs (Minneap) 2024;59:379–391. doi: 10.1016/j.gerinurse.2024.07.017. 2024/09/01/ [DOI] [PubMed] [Google Scholar]
  • 10.Xu B, Xu J, Wang C, Tang J. The effect of multi-sensory stimulation intervention on the agitation of patients with Alzheimer's disease. Article. Chin J Nurs Educ. 2023;20(1):98–102. doi: 10.3761/j.issn.1672-9234.2023.01.019. [DOI] [Google Scholar]
  • 11.Yang L, Yu W, Teng Z, et al. Effects of multi-sensory stimulation on apathy symptoms in elderly patients with Alzheimer's disease. Iran J Public Health. 2024;53(6) doi: 10.18502/ijph.v53i6.15908. 06/11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Verkaik R, van der Heide I, van Eerden E, Spreeuwenberg P, Scherder E, Francke A. Effects of enriched thematic multi-sensory stimulation on BPSD in a beach room: A pilot study among nursing-home residents with dementia. OBM Geriat. 2019;3(4):1–28. doi: 10.21926/obm.geriatr.1904092. [DOI] [Google Scholar]
  • 13.Solé C, Celdrán M, Cifre I. Psychological and behavioral effects of snoezelen rooms on dementia. Act Adapt Aging. 2023;47(4):550–565. doi: 10.1080/01924788.2022.2151805. [DOI] [Google Scholar]
  • 14.Oh S, Jang JS, Jeon AR, et al. Effectiveness of sensory integration therapy in children, focusing on Korean children: a systematic review and meta-analysis. World J Clin Cases. 2024;12(7):1260–1271. doi: 10.12998/wjcc.v12.i7.1260. Mar 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Helbling M, Grandjean M-L, Srinivasan M. Effects of multisensory environment/stimulation therapy on adults with cognitive impairment and/or special needs: a systematic review and meta-analysis. Special Care in Dentistry. 2024;44(2):381–420. doi: 10.1111/scd.12906. [DOI] [PubMed] [Google Scholar]
  • 16.Norwood MF, Lakhani A, Watling DP, Marsh CH, Zeeman H. Efficacy of multimodal sensory therapy in adult acquired brain injury: a systematic review. Neuropsychol Rev. 2022;33:693–713. doi: 10.1007/s11065-022-09560-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fitriyaningsih A, Dewi YLR, Adriani RB. Meta-analysis the effect of sensory integration therapy on sensoric and motoric development in children with autism spectrum disorder. J Maternal Child Health. 2021;7(1):52–63. doi: 10.26911/thejmch.2022.07.01.06. 01/16. [DOI] [Google Scholar]
  • 18.Johansson BB. Multisensory stimulation in stroke rehabilitation. Front Hum Neurosci. 2012;6:60. doi: 10.3389/fnhum.2012.00060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi: 10.1136/bmj.n160. Mar 29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.First MB, Clarke DE, Yousif L, Eng AM, Gogtay N, Appelbaum PS. DSM-5-TR: Rationale, process, and overview of changes. Psychiatr Serv. 2023;74(8):869–875. doi: 10.1176/appi.ps.20220334. [DOI] [PubMed] [Google Scholar]
  • 21.Serghiou S, Goodman SN. Random-effects meta-analysis: summarizing evidence with caveats. JAMA. 2019;321(3):301–302. doi: 10.1001/jama.2018.19684. [DOI] [PubMed] [Google Scholar]
  • 22.Cumming G. Routledge; 2012. Understanding the new statistics: effect sizes, confidence intervals, and meta-analysis. [Google Scholar]
  • 23.Gallardo-Gómez D, Richardson R, Dwan K. Standardized mean differences in meta-analysis: a tutorial. Cochrane Evid Synth Methods. 2024;2(3):e12047. doi: 10.1002/cesm.12047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jpt H. Cochrane handbook for systematic reviews of interventions. http://www.cochrane-handbookorg. 2008.
  • 25.Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557. Sep 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Spineli LM, Pandis N. Prediction interval in random-effects meta-analysis. Am J Orthod Dentofacial Orthop. 2020;157(4):586–588. doi: 10.1016/j.ajodo.2019.12.011. [DOI] [PubMed] [Google Scholar]
  • 27.Ding Q, Wan S, Dowling TC. Research and scholarly methods: subgroup analysis. Jaccp: J Am Coll Clin Pharm. 2022;5(5):551–558. doi: 10.1002/jac5.1611. 2022/05/01. [DOI] [Google Scholar]
  • 28.Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101. Dec. [PubMed] [Google Scholar]
  • 29.Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629. Sep 13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lin L, Chu H, Murad MH, et al. Empirical comparison of publication bias tests in meta-analysis. J Gen Intern Med. 2018;33(8):1260–1267. doi: 10.1007/s11606-018-4425-7. Aug. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Duval S, Tweedie R. Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–463. doi: 10.1111/j.0006-341X.2000.00455.x. [DOI] [PubMed] [Google Scholar]
  • 32.Mathur MB, VanderWeele TJ. Sensitivity analysis for publication bias in meta-analyses. J R Stat Soc Ser C Appl Stat. 2020;69(5):1091–1119. doi: 10.1111/rssc.12440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chandler J, Cumpston M, Li T, Page MJ, Welch V. Wiley; Hoboken: 2019. Cochrane handbook for systematic reviews of interventions. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898. Aug 28. [DOI] [PubMed] [Google Scholar]
  • 35.Milev RV, Kellar T, McLean M, et al. Multisensory stimulation for elderly with dementia: a 24-week single-blind randomized controlled pilot study. Am J Alzheimer's Dis Other Demen. 2008;23(4):372–376. doi: 10.1177/1533317508316681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bakshi R. New York University; 2004. Assessing the effectiveness of sensory stimulation on individuals who have moderate to severe dementia.https://search.ebscohost.com/login.aspx?direct=true&db=jlh&AN=109843336&login.asp&site=ehost-live&scope=site [Google Scholar]
  • 37.Hong GRS. Effects of multisensory stimulation using familiarity: Persons with dementia in long-term care facility in Korea. Article. J Korean Acad Nurs. 2011;41(4):528–538. doi: 10.4040/jkan.2011.41.4.528. [DOI] [PubMed] [Google Scholar]
  • 38.Maseda A, Sánchez A, Marante MP, González-Abraldes I, Buján A, Millán-Calenti JC. Effects of multisensory stimulation on a sample of institutionalized elderly people with dementia diagnosis: a controlled longitudinal trial. Am J Alzheimer's Dis Other Demen. 2014;29(5):463–473. doi: 10.1177/1533317514522540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sanchez A, Marante-Moar MP, Sarabia C, et al. Multisensory stimulation as an intervention strategy for elderly patients with severe dementia: a pilot randomized controlled trial. Am J Alzheimers Dis Other Demen. 2016;31(4):341–350. doi: 10.1177/1533317515618801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Staal JA, Sacks A, Matheis R, et al. The effects of Snoezelen (multi-sensory behavior therapy) and psychiatric care on agitation, apathy, and activities of daily living in dementia patients on a short term geriatric psychiatric inpatient unit. Int J Psychiatry Med. 2007;37(4):357–370. doi: 10.2190/pm.37.4.a. [DOI] [PubMed] [Google Scholar]
  • 41.Hutson C, Orrell M, Dugmore O, Spector A. Sonas: a pilot study investigating the effectiveness of an intervention for people with moderate to severe dementia. Am J Alzheimer's Dis Other Demen. 2014;29(8):696–703. doi: 10.1177/1533317514534756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Maseda A, Cibeira N, Lorenzo-Lopez L, et al. Multisensory stimulation and individualized music sessions on older adults with severe dementia: effects on mood, behavior, and biomedical parameters. J Alzheimer's Dis. 2018;63(4):1415–1425. doi: 10.3233/JAD-180109. [DOI] [PubMed] [Google Scholar]
  • 43.Andretta PG. ProQuest Information & Learning; 2008. The short-term effects of snoezelen treatment on patients with dementia.https://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=2008-99140-364&site=ehost-live&scope=site [Google Scholar]
  • 44.Mahdavi A, Besharat MA, Taghizadeh ME, Isazadeh S, Ehsan N, Rezaei A. Effectiveness of multi-sensory stimulations upon restoration of cognitive performance of patients exposed vascular dementia. Der Pharm Lett. 2015;7(7):19–22. [Google Scholar]
  • 45.Safavi M, Yahyavi SH, Farahani H, Mahmoudi N, Mahboubinia M. The effect of multi-sensory stimulation (MSS) on cognitive status of women with Alzheimer's disease in Fereshtegan elderly care center. J Jahrom Univ Med Sci. 2013;11(2):45–51. doi: 10.29252/jmj.11.2.7. Summer2013. [DOI] [Google Scholar]
  • 46.Yan Effect of multisensory stimulation on behavioral and psychological symptoms, cognitive function and quality of life in patients with senile dementia. Chin J Med Frontiers. 2018;10(2):97–101. doi: 10.12037/YXQY.2018.02-22. [DOI] [Google Scholar]
  • 47.Miller CWT, Hodzic V, Weintraub E. Current understanding of the neurobiology of agitation. West J Emerg Med. 2020;21(4):841–848. doi: 10.5811/westjem.2020.4.45779. Jul 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lewis RG, Florio E, Punzo D, Borrelli E. The Brain's reward system in health and disease. Adv Exp Med Biol. 2021;1344:57–69. doi: 10.1007/978-3-030-81147-1_4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Schaub C, Von Gunten A, Morin D, Wild P, Gomez P, Popp J. The effects of hand massage on stress and agitation among people with dementia in a hospital setting: a pilot study. Appl Psychophysiol Biofeedback. 2018;43(4):319–332. doi: 10.1007/s10484-018-9416-2. 2018/12/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Kwak S, Park S, Kim J, Park S, Lee JY. Multivariate neuroanatomical correlates of behavioral and psychological symptoms in dementia and the moderating role of education. Neuroimage Clin. 2020;28 doi: 10.1016/j.nicl.2020.102452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Le Heron C, Holroyd CB, Salamone J, Husain M. Brain mechanisms underlying apathy. J Neurol Neurosurg Psychiatry. 2019;90(3):302. doi: 10.1136/jnnp-2018-318265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Rolls ET. Emotion, motivation, decision-making, the orbitofrontal cortex, anterior cingulate cortex, and the amygdala. Brain Struct Funct. 2023;228(5):1201–1257. doi: 10.1007/s00429-023-02644-9. Jun. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hare BD, Duman RS. Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions. Mol Psychiatry. 2020;25(11):2742–2758. doi: 10.1038/s41380-020-0685-9. Nov. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Cameron A, Burns P, Garner A, et al. Making sense of multi-sensory environments: a scoping review. Int J Disabil Dev Ed. 2020;67(6):630–656. doi: 10.1080/1034912X.2019.1634247. [DOI] [Google Scholar]
  • 55.Zhang P, Duan L, Ou Y, et al. The cerebellum and cognitive neural networks. Review. Front Hum Neurosci. 2023;17 doi: 10.3389/fnhum.2023.1197459. 2023-July-28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Saragih ID, Tonapa SI, Saragih IS, Lee BO. Effects of cognitive stimulation therapy for people with dementia: a systematic review and meta-analysis of randomized controlled studies. Int J Nurs Stud. 2022;128 doi: 10.1016/j.ijnurstu.2022.104181. Apr. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

mmc1.docx (13.6KB, docx)
mmc2.docx (81KB, docx)
mmc3.pdf (8.3KB, pdf)
mmc4.pdf (68.1KB, pdf)

Articles from The Journal of Prevention of Alzheimer's Disease are provided here courtesy of Elsevier

RESOURCES